Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hughes, Mitchell E
11050  Ergebnisse:
Personensuche X
?
1

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidenc..:

Bowers, Jackson T. ; Anna, Jacob ; Bair, Steven M....
Blood Advances.  7 (2023)  21 - p. 6630-6638 , 2023
Link: https://doi.org/10.1182/..
 
?
2

High-grade B-cell lymphoma, not otherwise specified: a mult..:

Zayac, Adam S. ; Landsburg, Daniel J. ; Hughes, Mitchell E....
Blood Advances.  7 (2023)  21 - p. 6381-6394 , 2023
Link: https://doi.org/10.1182/..
 
?
3

Outcomes of Tisagenlecleucel in Lymphoma Patients With Pred..:

Nasta, Sunita D. ; Hughes, Mitchell E. ; Namoglu, Esin C....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  8 - p. e730-e737 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Addressing the Challengesof Novel Oncology and Hematology T..:

Wyatt, Houston ; Zuckerman, Autumn D. ; Hughes, Mitchell E...
Journal of Oncology Pharmacy Practice.  28 (2022)  3 - p. 627-634 , 2022
Link: https://doi.org/10.1177/..
 
?
5

New and emerging therapies for the treatment of relapsed/re..:

Moore, Donald C. ; Peery, Matthew R. ; Tobon, Katherine A....
Journal of Oncology Pharmacy Practice.  28 (2022)  8 - p. 1848-1858 , 2022
Link: https://doi.org/10.1177/..
 
?
6

Prognostic Factors of PTLD after SOT:

, In: Post-Transplant Lymphoproliferative Disorders,
Tsai, Donald E. ; Hughes, Mitchell E. - p. 149-165 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Characterizing the Incidence of Pneumonitis in Haploidentic..:

Cenin, Danielle A. ; Manjunath, Shwetha H. ; Freyer, Craig W....
Transplantation and Cellular Therapy.  27 (2021)  3 - p. S455-S457 , 2021
Link: https://doi.org/10.1016/..
 
?
8

18F-Fluorodeoxyglucose Positron Emission Tomography/Compute..:

Ruff, Andrew ; Ballard, Hatcher J. ; Pantel, Austin R....
Molecular Imaging and Biology.  23 (2021)  6 - p. 818-826 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Appropriate prescribing of antiemetics with oral oncolytic ..:

Suen, Connie T. ; Hughes, Mitchell E. ; Timlin, Colleen...
Journal of Drug Assessment.  8 (2019)  sup1 - p. 12-12 , 2019
Link: https://doi.org/10.1080/..
 
?
10

Treatment of Patients With Relapsed/Refractory Non-Hodgkin ..:

Hughes, Mitchell E. ; Landsburg, Daniel J. ; Rubin, Daniel J....
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  12 - p. 791-798 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Outcomes of patients with relapsed/refractory double-expres..:

Landsburg, Daniel J. ; Hughes, Mitchell E. ; Koike, Alexa...
Blood Advances.  3 (2019)  2 - p. 132-135 , 2019
Link: https://doi.org/10.1182/..
 
?
12

Oral Vancomycin Prophylaxis Is Highly Effective in Preventi..:

Ganetsky, Alex ; Han, Jennifer H ; Hughes, Mitchell E...
Clinical Infectious Diseases.  68 (2018)  12 - p. 2003-2009 , 2018
Link: https://doi.org/10.1093/..
 
?
13

Primer on Chronic Lymphocytic Leukemia: Part II:

Hughes, Mitchell E. ; Gill, Jennifer
The Journal for Nurse Practitioners.  14 (2018)  4 - p. 309-315.e2 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Primer on Chronic Lymphocytic Leukemia: Part I:

Gill, Jennifer ; Hughes, Mitchell E.
The Journal for Nurse Practitioners.  14 (2018)  4 - p. 302-308 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Carbodiimide Induced Cross-Linking, Ligand Addition, and De..:

Cammarata, Christopher R. ; Hughes, Mitchell E. ; Ofner III, Clyde M.
Molecular Pharmaceutics.  12 (2015)  3 - p. 783-793 , 2015
Link: https://doi.org/10.1021/..
 
1-15